Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 21, 2025

Pediatric Parapneumonic Effusion and Empyema Cases After Relaxation of COVID-19 Pandemic Restrictions in Türkiye

View Full Paper
Ask AI
Bookmark
Share

Authors

ŞBŞefika Elmas Bozdemir

Discussion

Loading...

Member takes

Overview

Analysis compares pediatric parapneumonic effusion and empyema cases pre- and post-COVID restrictions, indicating significant trends in clinical outcomes.

Key Points

  • An increase in pediatric cases of parapneumonic effusion was observed after COVID-19 restrictions were lifted, highlighting potential impacts on children's health.
  • In total, 58 pediatric patients were analyzed, with a notable rise from 15 cases in 2021-2022 to 43 in 2022-2023, although not statistically significant.
  • Observational analysis utilized pediatric case records from two winter-spring periods to assess changes in clinical and demographic attributes.
  • Findings suggest a need for larger multicenter studies to better understand the implications of post-pandemic pediatric health trends.

Cite This Study

Şefika Elmas Bozdemir (2025) studied this question.

synapsesocial.com/papers/68d43a0d713b0b5dfea7a992https://doi.org/10.46889/jcim.2025.6301
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Incidence, etiologies, and outcomes of severe pediatric community-acquired empyema before and after the pandemic: an Italian multicentric study2025
  2. 2Parapneumonic Effusion Versus Pulmonary Empyema in Children: Analysis of Risk Factors and Laboratory Predictors Through a Single Center Experience2025
  3. 3Long‐Term Outcomes of Necrotizing Pneumonia and Parapneumonic Effusion in Children2025
  4. 4Prevalence of pleural effusion over eight years among Egyptian children in the delta region: a single center retrospective cross-sectional study2025
  5. 5Evolving clinical features of Mycoplasma pneumoniae infections following COVID-19 pandemic restrictions: a retrospective, comparative cohort study2025